1. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors Conditions: Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma; hematopoietic and lymphoid cancer; Neuroblastoma; Osteosarcoma |
2. | | Recruiting | Alanosine in Treating Patients With Cancer Conditions: Gastrointestinal Cancer; musculoskeletal cancer; Osteosarcoma; thorax and respiratory cancer |
3. | | Recruiting | Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma Conditions: Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma; hematopoietic and lymphoid cancer; Osteosarcoma |
4. | | Recruiting | Neoadjuvant and Adjuvant Pamidronate With Induction and Maintenance Chemotherapy in Treating Patients With Osteosarcoma Conditions: localized osteosarcoma; metastatic osteosarcoma |
5. | | Recruiting | Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma Conditions: metastatic osteosarcoma; recurrent osteosarcoma; lung metastases |
6. | | Recruiting | Gemcitabine and Docetaxel to Treat Bone and Soft Tissue Cancers Conditions: Osteosarcoma; Sarcoma, Ewing's; Chondrosarcoma |
7. | | Recruiting | Temozolomide and O6-Benzylguanine for Treating Childhood Cancers Conditions: Brain Neoplasm; Embryonal Neoplasm; Ewing's Sarcoma; Germ Cell Neoplasm; Liver Neoplasm; Nephroblastoma; Osteosarcoma; Rhabdomyosarcoma; Sarcoma |
8. | | Recruiting | Bone Cancer: Treatment Outcome Based on Tumor Response Condition: Osteosarcoma |
9. | | Recruiting | Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors Conditions: childhood rhabdomyosarcoma; childhood soft tissue sarcoma; female reproductive cancer; Gastrointestinal Cancer; musculoskeletal cancer; Osteosarcoma |
10. | | Recruiting | Irinotecan in Treating Children With Refractory Solid Tumors Conditions: Ewing's family of tumors; childhood brain tumor; childhood rhabdomyosarcoma; childhood solid tumor; Neuroblastoma; Osteosarcoma |
11. | | Recruiting | Study of AP23573, an mTOR Inhibitor, in Patients with Advanced Sarcoma Conditions: Leiomyosarcoma; Liposarcoma; Osteosarcoma; Sarcoma, Soft Tissue; Metastases |
12. | | Not yet recruiting | Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma Conditions: recurrent tumors of the Ewing's family; Chondrosarcoma; recurrent osteosarcoma |
13. | | Recruiting | Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma Condition: metastatic osteosarcoma |
14. | | Recruiting | Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma Conditions: recurrent childhood acute lymphoblastic leukemia; recurrent childhood lymphoblastic lymphoma; recurrent osteosarcoma; ... |
15. | | Recruiting | Evaluation, Treatment, and Natural History of Children with Cancer Conditions: Ewing's Sarcoma; Leukemia; Lymphoma; Neoplasm; Sarcoma |
16. | | Recruiting | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer Conditions: Breast Cancer; Gastrointestinal Cancer; Kidney Cancer; Musculoskeletal Cancer; Reproductive Cancer; Skin Cancer |
17. | | Not yet recruiting | Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer Conditions: Cachexia; Cancer; Pain |
18. | | Recruiting | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer Condition: Cancer |
19. | | Recruiting | Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors Condition: childhood cancer |
20. | | Recruiting | Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Condition: Cancer |
21. | | Recruiting | ABT-751 in Treating Young Patients With Refractory Solid Tumors Condition: childhood cancer |
22. | | Recruiting | Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors Condition: childhood cancer |
23. | | Recruiting | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors Condition: Cancer |
24. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma Condition: Cancer |
25. | | Not yet recruiting | Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma Conditions: Ewing's family of tumors; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; childhood rhabdomyosarcoma; Neuroblastoma |
26. | | Not yet recruiting | Ecteinascidin 743 in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors Conditions: recurrent childhood rhabdomyosarcoma; previously treated childhood rhabdomyosarcoma; recurrent childhood soft tissue sarcoma; ... |
27. | | Recruiting | Studying Genetic Changes in Ewing Sarcoma Tumors Condition: Ewing's Sarcoma |
28. | | Recruiting | Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor Condition: recurrent tumors of the Ewing's family |
29. | | Recruiting | Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors Conditions: Ewing's family of tumors; adult solid tumor; childhood brain tumor; childhood solid tumor; Gastrointestinal Cancer; Neuroblastoma |
30. | | Recruiting | Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma Conditions: localized tumors of the Ewing's family; metastatic tumors of the Ewing's family; recurrent tumors of the Ewing's family |
31. | | Recruiting | Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) With or Without ImmTher for Newly Diagnosed High Risk Ewing's Sarcoma Condition: Ewing's Sarcoma |
32. | | Recruiting | Combination Chemotherapy and Peripheral Stem Cell Transplantation With or Without Radiation Therapy and/or Surgery in Treating Patients With Ewing's Sarcoma Conditions: localized tumors of the Ewing's family; metastatic tumors of the Ewing's family |
33. | | Recruiting | P-glycoprotein Antagonist, Tariquidar, in Combination with Doxorubicin (Adriamycin), Vinorelbine (Navelbine), or Docetaxel to Treat Children with Solid Tumors Conditions: Brain Tumor; Ewing's Sarcoma; Neuroblastoma; Rhabdomyosarcoma |
34. | | Recruiting | Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor Condition: localized tumors of the Ewing's family |
35. | | Recruiting | Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts after Intensive Chemotherapy Conditions: Ewing's Sarcoma; Rhabdomyosarcoma; Sarcoma; Synovial Sarcoma |
36. | | Recruiting | Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma Conditions: Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma |
37. | | Recruiting | A Pilot Study of Autologous T-Cell Transplantation with Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas Conditions: Ewing's Sarcoma; Rhabdomyosarcoma |
38. | | Not yet recruiting | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment Condition: Cancer |
39. | | Recruiting | Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma Condition: adult soft tissue sarcoma |
40. | | Recruiting | Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer Conditions: bone marrow ablation; Cancer |
41. | | Recruiting | A Phase I Study of Single Agent OSI-774 (Tarceva) Followed by OSI-774 with Temozolomide for Patients with Selected Recurrent/Refractory Solid Tumors, Including Brain Tumors Condition: Neoplasms |